Cellbxhealth PLC Overview
Get informed when a big investor buys or sells
+ Follow-475.19%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for ANPCF is -475.19%. That is below the sector sector average of 11.64%. Investors often review this figure alongside Cellbxhealth PLC's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, ANPCF currently prints -475.19% for ROE, while the sector average sits near 11.64%. That is roughly 4183.6% below the sector mean. Large gaps often invite a closer look at Cellbxhealth PLC's growth, margins, and balance sheet.
Return on Equity shows how effectively Cellbxhealth PLC converts resources into returns. At -475.19%, ANPCF may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting ANPCF's ROE (-475.19%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
